Francesca Canalias1, Ester García, Maribel Sánchez. 1. Laboratori de Referència d'Enzimologia Clínica, Departament de Bioquímica i de Biologia Molecular, Unitat de Bioquímica de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. francesca.canalias@uab.cat
Abstract
BACKGROUND: The International Standard ISO 18153 describes how to assure the metrological traceability of catalytic concentration values assigned to commercial calibration materials following the reference measurement system. We applied this approach to the standardization of alpha-amylase measurements. METHODS: Traceable values of catalytic activity with measurement uncertainty were assigned to three commercial calibrator materials using alpha-amylase primary reference measurement procedure described by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). The metrological traceable to the SI units calibration was validated by measuring human serum and plasma samples using the primary reference procedure and two routine commercial measurement procedures using different substrates (4,6-ethylidene(G1)-4-nitrophenyl(G7)-alpha-(1-->4)-D-maltoheptaoside (EPS) and 2-chloro-4-nitrophenyl-alpha-D-maltotrioside (CNP)) and calibrated with the traceable materials. Previously the commutability of the commercial calibration materials was verified. RESULTS: Procedures comparison showed that the primary reference procedure and routine procedures have the same analytical specificity. The commercial calibrators tested showed to be commutable and were used to recalibrate the routine measurement procedures. The agreement of procedures improves after recalibration with commutable calibrator materials. CONCLUSIONS: The implementation of a reference system for alpha-amylase measurements was demonstrated that assures the traceability of patients' results to SI units and to harmonize the results obtained by two different routine procedures.
BACKGROUND: The International Standard ISO 18153 describes how to assure the metrological traceability of catalytic concentration values assigned to commercial calibration materials following the reference measurement system. We applied this approach to the standardization of alpha-amylase measurements. METHODS: Traceable values of catalytic activity with measurement uncertainty were assigned to three commercial calibrator materials using alpha-amylase primary reference measurement procedure described by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). The metrological traceable to the SI units calibration was validated by measuring human serum and plasma samples using the primary reference procedure and two routine commercial measurement procedures using different substrates (4,6-ethylidene(G1)-4-nitrophenyl(G7)-alpha-(1-->4)-D-maltoheptaoside (EPS) and 2-chloro-4-nitrophenyl-alpha-D-maltotrioside (CNP)) and calibrated with the traceable materials. Previously the commutability of the commercial calibration materials was verified. RESULTS: Procedures comparison showed that the primary reference procedure and routine procedures have the same analytical specificity. The commercial calibrators tested showed to be commutable and were used to recalibrate the routine measurement procedures. The agreement of procedures improves after recalibration with commutable calibrator materials. CONCLUSIONS: The implementation of a reference system for alpha-amylase measurements was demonstrated that assures the traceability of patients' results to SI units and to harmonize the results obtained by two different routine procedures.